Vimarsana
Biggest News Aggregation in the World

James Westcott News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from James Westcott. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In James Westcott Today - Breaking & Trending Today

London launch of Ad Hoc Baroque - Announcements - Vimarsana News

London launch of Ad Hoc Baroque - Announcements

Rotor presents Ad Hoc Baroque: Marcel Raymaekers’ Salvage Architecture in Postwar Belgium.

Source: e-flux.com
ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program for Treatment of Gastrointestinal Disease and Cancers - Vimarsana News

ThirtyFiveBio Awarded Innovate UK Biomedical Catalyst Grant to Advance GPR35 Inhibitor Program for Treatment of Gastrointestinal Disease and Cancers

/PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for...

Demand for biomethane hits all-time high as Gasrec sales soar - Vimarsana News

Demand for biomethane hits all-time high as Gasrec sales soar

Demand for biomethane hits all-time high as Gasrec sales soar - Biomethane - FleetPoint

Canaan-Backed Biotech Gives Orphan Receptor a Home and New Role in Gut Cancer Drugs - Vimarsana News

Canaan-Backed Biotech Gives Orphan Receptor a Home and New Role in Gut Cancer Drugs

ThirtyFiveBio aims to treat gastrointestinal cancer by targeting a so-called orphan receptor called GPR35. The biotech startup is revealing its science at the American Association of Cancer Research annual meeting.

ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023 - Vimarsana News

ThirtyFiveBio Emerges From Stealth with Presentation of First Data from GPR35 Antagonist Program at American Association for Cancer Research (AACR) Annual Meeting 2023

/PRNewswire/ -- ThirtyFiveBio Limited, a biotechnology company developing first-in-class small molecule inhibitors of G protein-coupled receptor 35 (GPR35) for...